Facebook-f Instagram Linkedin Youtube Tiktok

Strategic Project FFC Research

Strategic Project FFC Research

Assessing the safety and clinical potential of GY971, an anti-inflammatory compound for cystic fibrosis
€ 0 still needed
0%
€ 0 goal

pRINCIPAL INVESTIGATOR

Giulio Cabrini (Department of Life Sciences and Biotechnology, University of Ferrara), Marco Prosdocimi (FFC Ricerca Research Valorization Initiative; Center on Innovative Therapies for Cystic Fibrosis InnThera4CF, University of Ferrara)

Partner

Sjoerd Hak (Stiftelsenfor INdustriell og Teknisk Forskning – SINTEF, Trondheim, Norway), Ilaria Lampronti (Department of Life Sciences and Biotechnology, University of Ferrara), Adriana Chilin (Department of Pharmaceutical and Pharmacological Sciences, University of Padua), Alessandra Bragonzi (Infection and Cystic Fibrosis Unit, IRCSS San Raffaele Scientific Institute, Milan), Nicoletta Pedemonte (Medical Genetics Unit, IRCSS Giannina Gaslini Institute, Genoa)

Researchers

8

Category

AREA 4 Lung inflammation

Duration

1 year

Goal

Funds raised

Objectives

The introduction of CFTR modulators

who adopted the project

roberto 50

€ 8.000

armitoteatro

€ 10.000

delegazione ffc ricerca di cecina e rosignano

€ 30.000

delegazione ffc ricerca di crotone “vita in te ci credo”

€ 30.000

OTHER PROJECTS

Discover the other projects

FFC Ricerca 2025 strategic project: De-risking GY

Assessing the safety and clinical potential of GY971, an anti-inflammatory compound for cystic fibrosis
READ MORE
READ MORE

FFC Ricerca 2025-2028 strategic project: MindKids-CF

Development of screening and monitoring tools for anxiety, depression, and behavior Problems in Italian Children with Cystic Fibrosis under 12 Years of Age
READ MORE
READ MORE

FFC Ricerca 2025 strategic project: 1 in 30 and you don’t know it. Phase 4

An information and awareness campaign on the test of the healthy carrier of cystic fibrosis.
READ MORE
READ MORE